Lower prescription drug costs for Inland Empire families and seniors by empowering Medicare to negotiate drug prices directly with manufacturers and capping out-of-pocket insulin costs at $35 per month.

Stated position. What this official has said they believe on this issue — a sourced claim, shown distinctly from any assessment of what they did. It is never scored and never affects the Integrity Score.

Derived from a tracked promise: “Lower prescription drug costs for Inland Empire families and seniors by empowering Medicare to negotiate drug prices directly with manufactu…”

Sources

Office of Rep. Pete Aguilar (aguilar.house.gov)https://aguilar.house.gov/2022/04/04/rep-aguilar-votes-to-make-insulin-affordable-for-the-inland-empire/ ↗
“No one should have to make the choice between lifesaving medicine and putting food on the table.”
Office of Rep. Pete Aguilar (aguilar.house.gov)https://aguilar.house.gov/2023/08/16/rep-aguilar-highlights-lower-health-care-costs-one-year-after-passage-of-inflation-reduction-act/ ↗
“allowing Medicare to negotiate directly with drug companies on the price of prescription drugs”
Inland Empire Community Newspapershttps://iecn.com/over-108000-californians-on-medicare-to-see-35-insulin-cap-inland-empire-to-benefit-from-healthcare-savings/ ↗
“the $35 insulin cost cap is set to benefit 108,164 Californians on Medicare who use insulin”